🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The main objective of this study is to see whether the favorable preventati...
Status
Completed
Location
Tartu University Clinics
Start Date
2021-04-09
Trial ID
NCT04574713
Treatments Being Tested
This study examines the long term safety and efficacy of the Fixed Dose com...
Status
Completed
Location
Multiple Locations
Start Date
2013-02-14
Trial ID
NCT01788358
The purpose of this survey is to investigate the safety and efficacy of lon...
Status
Completed
Location
Multiple Locations
Start Date
2010-06-15
Trial ID
NCT02068495
Treatments Being Tested
The aim is to compare the blood pressure lowering effect of the combination...
Status
Completed
Location
Research Site
Start Date
2007-01
Trial ID
NCT00434967
Treatments Being Tested
The purpose of this study is to evaluate the efficacy and safety of TCV-116...
Status
Withdrawn
Location
Fuwai Hospital
Start Date
2017-05-09
Trial ID
NCT02969265
Treatments Being Tested
This study examines the efficacy and safety of the Fixed Dose combination B...
Status
Withdrawn
Location
Fondazione Università G.D'Annunzio
Start Date
2017-12-01
Trial ID
NCT02047019
Treatments Being Tested
The purpose of this study is to determine the efficacy of candesartan, once...
Status
Completed
Location
Multiple Locations
Start Date
2006-10
Trial ID
NCT00775814
Treatments Being Tested
The purpose of this study is to evaluate the safety and efficacy of long-te...
Status
Completed
Location
Multiple Locations
Start Date
2009-04-01
Trial ID
NCT02016183
Treatments Being Tested
This is a two part introductory clinical trial with MK-5478. Part I will ev...
Status
Completed
Location
Multiple Locations
Start Date
2009-12-01
Trial ID
NCT01025843
Treatments Being Tested
This will be an open-label, randomized, single dose, two-way crossover stud...
Status
Completed
Location
GSK Investigational Site
Start Date
2013-12-11
Trial ID
NCT02006589